n(g)-iminoethylornithine has been researched along with Brain Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarkson, AN; Connor, BJ; Sun, Y; Van Slooten, AR | 1 |
| Connell, B; Saleh, TM; Wilson, BC | 1 |
2 other study(ies) available for n(g)-iminoethylornithine and Brain Infarction
| Article | Year |
|---|---|
L-NIO as a novel mechanism for inducing focal cerebral ischemia in the adult rat brain.
Topics: Animals; Blood-Brain Barrier; Brain Infarction; Brain Ischemia; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Jugular Veins; Male; Movement Disorders; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Ornithine; Rats; Rats, Sprague-Dawley; Time Factors | 2015 |
Relaxin-induced reduction of infarct size in male rats receiving MCAO is dependent on nitric oxide synthesis and not estrogenic mechanisms.
Topics: Analysis of Variance; Animals; Brain Infarction; Drug Interactions; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Nitric Oxide; Ornithine; Rats; Relaxin; Tetrazolium Salts | 2006 |